Trial Profile
Combivent UDV vs. salbutamol UDV (2.5mg) for treatment of an acute exacerbation of asthma in children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Mar 2008
Price :
$35
*
At a glance
- Drugs Ipratropium-bromide/salbutamol (Primary) ; Salbutamol
- Indications Acute asthma
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 07 Mar 2008 Status changed from in progress to completed, according to ClinicalTrials.gov
- 17 Jul 2006 New trial record.